The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Unfortunately many of the market indicators are bearish for this stock...hence the almost daily drops..needs news fast and a decent rns could turn this around fast but without news the drift will continue
Three reasons why .....
3 years accounts required showing a minimum turnover...
Sufficient liquidity within the company to support a contract ...liquidity ratio would need to be around 1.5...
Profitability?
Unlikely to pass tests both for government and large private contracts.
Updated on TSX...
THE company has requested a short extension to the 14th July for interim filing of accounts...awaiting confirmation of acceptance
Yes the app failed today on a number of rns updates...always worth having a few apps as back up...
I always have the main london stock exchange..as the fall back...
The funding requirements have been known for some time..the key is that working capital is covered which it is...this is a very small mcap (8)m vs future valuations..very strong chance that future funding is partially covered by jv with even a buyout a possibility.
Couldn't agree more.
Unfortunately without any commercial revenue streams the chances of enticing a sizeable contract are next to nil...as I mentioned before it's just a vanity project or call it a hobby for the bod.
Apart from the badminton club of course.
What happened to the all trumpets blazing AFI-ID? Lots of trials...and trials without ever finishing a project or coming to a commercial conclusion good or bad ...Sure sign of a lifestyle company.
Would love to be proved wrong but somehow I Don,t think it's going to happen. Imo.
Yet another aim vanity project designed to just intrigue investors enough with periodic updates on ventures whilst never actually achieving anything.
Have you noticed how we have never received any updates on afri-id...even though this was supposedly trialed last year.
This should never of been allowed to pass the ipo stage..
Regulations need to tighten up...needs to be a credible business plan with a realistic chance of turnover yet alone profit within a designated period with only 4 placings allowed. Working capital needs to be in place with sufficient funds.
Yes unfortunately it would appear we have been led up the garden path by a somewhat inept CEO.
Nothing ever gets finalised contract or no contract.
A real shame.
The problem here is possibly one of consistency..there was a trading up date on the 29th May 2020 ...so market was probably expecting ...
The various areas the testing is involved in mean that any jv or takeover will make this multiple ten fold...small mcap reward vs risk is now very good.
What's happened to the business opportunities ...last update 5th Nov 2020 , over 6 months now,
Mou was in.place with a view to commercialisation. No updates or progress reports....the fact that this company never seems to be able to complete or progress to completion any significant commercial contract since its formation speaks volumes. It would seem that the business was formed and is operating purely as an employment mechanism with no realistic opportunities to generate revenue yet alone a profit. Working capital raises would appear to be the only sure thing..wish I was wrong ...
I think the only business plan they have is to ensure the salaries are paid.
As far as I can see from the last 12 months of news reports and let's be honest apart from the age and annual report and one update over 12 months ago nothing has happened. This is the sort of company the fca should look at and close down. Of course this is my opinion but how long do you keep stringing out investors..
Anyone know what's happened to the afrik I'd trial..no news for several months.
I think we also need to remember whilst AZ is the primary focal point the company has some leading experts in their field. Suzanne Chishti is a one of the foremost leaders on fintech with very creditable positions behind her.AZ will be well served by these experts and hopefully as shareholders we will be well rewarded.
Yes a jv a possibility or multiple smaller contracts but likely to be limited regards revenue generation.
Possible overseas contract where requirements for trading statements are as rigid
In my opinion the company is unlikely to win any government or large corporate contracts because it simply won't meet the tender contractual requirements covering 3 years of audit accounts.
Covering financial operational and a key area liquidity.
This could be a 10 bagger
Check out the above 96m mcap 100%...